Edgewise Therapeutics, Inc.(EWTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

EWTX Edgewise Therapeutics, Inc.

休市中 08-16 16:00:00 EDT

18.45

-0.42

-2.23%

盘后18.45

+0.000.00%

19:56 EDT

最高19.20	最低18.05	成交量56.04万
今开18.88	昨收18.87	日振幅6.09%
总市值17.30亿	流通市值9.72亿	总股本9,377万
成交额1,036万	换手率1.06%	流通股本5,270万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"EWTX","market":"US","secType":"STK","nameCN":"Edgewise Therapeutics, Inc.","latestPrice":18.45,"timestamp":1723838400000,"preClose":18.87,"halted":0,"volume":560400,"hourTrading":{"tag":"盘后","latestPrice":18.45,"preClose":18.45,"latestTime":"19:56 EDT","volume":40224,"amount":742140.98,"timestamp":1723852588182},"delay":0,"floatShares":52699791,"shares":93772288,"eps":-1.498438,"marketStatus":"休市中","marketStatusCode":7,"change":-0.42,"latestTime":"08-16 16:00:00 EDT","open":18.88,"high":19.2,"low":18.05,"amount":10356451.4652,"amplitude":0.060943,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.498438,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1724054400000},"adr":0,"listingDate":1616731200000,"adjPreClose":18.87,"preHourTrading":{"tag":"盘前","latestPrice":18.9,"preClose":18.87,"latestTime":"04:10 EDT","volume":2,"amount":37.8,"timestamp":1723795815522},"postHourTrading":{"tag":"盘后","latestPrice":18.45,"preClose":18.45,"latestTime":"19:56 EDT","volume":40224,"amount":742140.98,"timestamp":1723852588182},"volumeRatio":0.571021688745181,"impliedVol":1.5261,"impliedVolPercentile":0.9683},"requestUrl":"/m/hq/s/EWTX","defaultTab":"news","newsList":[{"id":"1183248636","title":"异动解读 | Edgewise Therapeutics盘中大涨7.45% 机构看好前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1183248636","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183248636?lang=zh_cn&edition=full","pubTime":"2024-08-16 00:30","pubTimestamp":1723739425,"startTime":"0","endTime":"0","summary":"北京时间2024年8月15日,生物制药公司Edgewise Therapeutics, Inc.股价在盘中出现大涨,最高上涨7.45%,报收17.95美元/股。公开消息显示,EWTX股价在当日盘中一度急速拉升5.28%,引发市场关注。分析人士认为,这可能与机构对该公司前景看好有关。Edgewise Therapeutics是一家临床阶段的生物制药公司,专注于开发治疗严重罕见肌肉疾病的创新疗法。公司正在研发口服小分子药物治疗肌肉骨骼疾病,在这一领域具有较强的竞争力。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EWTX"],"gpt_icon":0},{"id":"2459223477","title":"Edgewise Therapeutics, Inc.2024财年第二财季实现净利润-31.50百万美元，同比减少46.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459223477","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459223477?lang=zh_cn&edition=full","pubTime":"2024-08-16 00:03","pubTimestamp":1723737809,"startTime":"0","endTime":"0","summary":"8月16日，Edgewise Therapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为-31.50百万美元，同比减少46.72%；其中营业收入为0.00美元，每股基本收益为-0.34美元。从资产负债表来看，Edgewise Therapeutics, Inc.总负债21.17百万美元，其中短期债务988000.00美元，资产负债比为0.26，流动比率为0.31。机构评级：截至2024年8月16日，当前有6家机构对Edgewise Therapeutics, Inc.目标价做出预测，其中目标均价为33.17美元，其中最低目标价为25.00美元，最高目标价为48.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816000336959be702&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816000336959be702&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","EWTX"],"gpt_icon":0},{"id":"2459420495","title":"Edgewise Therapeutics, Inc.盘中异动 急速拉升5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459420495","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459420495?lang=zh_cn&edition=full","pubTime":"2024-08-15 21:31","pubTimestamp":1723728667,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日21时31分，Edgewise Therapeutics, Inc.股票出现异动，股价急速拉升5.28%。截至发稿，该股报17.95美元/股，成交量9182股，换手率0.01%，振幅1.58%。Edgewise Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。其相关个股中，Cingulate Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 、Nutriband Inc C/Wts 涨幅较大，Cingulate Inc.、Scisparc Ltd.、Altamira Therapeutics Ltd.较为活跃，换手率分别为2303.07%、1455.32%、333.77%，振幅较大的相关个股有Cingulate Inc.、Celcuity Inc.、Absci Corporation，振幅分别为28.18%、9.31%、9.11%。Edgewise Therapeutics, Inc.公司简介：Edgewise Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815213107a1d47055&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815213107a1d47055&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EWTX","BK4007","LENZ","BK4539","BK4139"],"gpt_icon":0},{"id":"2458749620","title":"美国研究综述-Airbnb、通用美元、沃尔玛","url":"https://stock-news.laohu8.com/highlight/detail?id=2458749620","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458749620?lang=zh_cn&edition=full","pubTime":"2024-08-12 15:40","pubTimestamp":1723448430,"startTime":"0","endTime":"0","summary":"    路透8月12日 - 华尔街证券分析师周一调整了对多家美国上市公司的评级和目标价，其中包括 Airbnb、Dollar General 和沃尔玛。要闻             * Airbnb Inc   ：杰富瑞将目标价从 150 美元下调至 125 美元              * Dollar General Corp   ：杰富瑞将目标价从160美元下调至145美元             * Hilton Grand Vacations Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性\"。* Pacira Biosciences Inc   ：摩根大通将目标价从45美元下调至10美元              * Pacira Biosciences Inc   ：Piper Sandler将目标价从42美元下调至11美元             * Pacira Biosciences Inc   ：Piper Sandler将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066051225.USD","ROK","RDFN","HBI","ARDT","HGV","GSHD","HSIC","RDNT","BWIN","LU0211327993.USD","BK4175","BTAI","BJ","CBUS","DLTR","EWTX","LU1069347547.HKD","SWIM","STEP","ZD","BK4173","CCOI","SKY","OKE","DG","IE0034390439.USD","LEGH","EXPE","NNI","GHLD","LU2361045086.USD","OPAD","CC","PCRX","BK4535","LU2361044949.HKD","ITOS","CARG","ABNB","HLMN","FTDR","BURL","GCMG","FMC","PX","NTLA","LU2361044865.SGD","WMT"],"gpt_icon":1},{"id":"2457077846","title":"Edgewise Therapeutics Inc    预计每股亏损 34 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457077846","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457077846?lang=zh_cn&edition=full","pubTime":"2024-08-07 02:32","pubTimestamp":1722969162,"startTime":"0","endTime":"0","summary":"   * Edgewise Therapeutics Inc    预计在8月8日公布截至0001年1月1日的业绩时，季度收入将没有变化(预计)。*    * LSEG分析师对Edgewise Therapeutics Inc的平均预期是每股亏损34美分。* 华尔街对 Edgewise Therapeutics Inc 的 12 个月目标价中位数为 32.00 美元，高于其上次收盘价 15.89 美元。8月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","EWTX"],"gpt_icon":0},{"id":"2454328342","title":"Edgewise Therapeutics, Inc.盘中异动 股价大涨5.05%报19.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454328342","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454328342?lang=zh_cn&edition=full","pubTime":"2024-07-26 21:44","pubTimestamp":1722001474,"startTime":"0","endTime":"0","summary":"北京时间2024年07月26日21时44分，Edgewise Therapeutics, Inc.股票出现异动，股价急速拉升5.05%。截至发稿，该股报19.68美元/股，成交量5.1848万股，换手率0.06%，振幅4.54%。Edgewise Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，Windtree Therapeutics, Inc.、Nutriband Inc C/Wts 、Cel-Sci Corporation涨幅较大，Windtree Therapeutics, Inc.、Novabay Pharmaceuticals, Inc.、Cel-Sci Corporation较为活跃，换手率分别为3555.08%、114.52%、57.42%，振幅较大的相关个股有Windtree Therapeutics, Inc.、Cel-Sci Corporation、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为56.23%、49.58%、26.50%。Edgewise Therapeutics, Inc.公司简介：Edgewise Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726214435af945996&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726214435af945996&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EWTX","LENZ","BK4007","BK4539","BK4139"],"gpt_icon":0},{"id":"2454382913","title":"成分股MeiraGTx收涨11.62%，AC Immune涨10.76%，诺瓦瓦克斯医药涨8.25%表现第三，和黄医药则收跌3.","url":"https://stock-news.laohu8.com/highlight/detail?id=2454382913","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454382913?lang=zh_cn&edition=full","pubTime":"2024-07-26 04:45","pubTimestamp":1721940358,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["BK4135","BK4585","BK4531","BK4139","00013","BK1191","BK1587","HCM","NVAX","AC","BK4547","BK4539","EWTX","LENZ","BK4588","BK4007","BK4568","BK1588","JANX"],"gpt_icon":0},{"id":"2450824715","title":"成分股uniQure收涨51.72%，延续7月9日涨76.46%的表现；Amylyx Pharmaceutical涨25.","url":"https://stock-news.laohu8.com/highlight/detail?id=2450824715","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450824715?lang=zh_cn&edition=full","pubTime":"2024-07-11 06:37","pubTimestamp":1720651031,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["ZNTL","FULC","BK4139","BK4539","OCUL","LENZ","EWTX","AMRN","BK4007","KYMR"],"gpt_icon":0},{"id":"2450824369","title":"成分股uniQure收涨51.72%，延续7月9日涨76.46%的表现；Amylyx Pharmaceutical涨25.","url":"https://stock-news.laohu8.com/highlight/detail?id=2450824369","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450824369?lang=zh_cn&edition=full","pubTime":"2024-07-11 06:00","pubTimestamp":1720648815,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/us-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/us-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["BK4539","BK4007","OCUL","EWTX","KYMR","FULC","ZNTL","LENZ","BK4139","AMRN"],"gpt_icon":0},{"id":"2450975818","title":"加拿大皇家银行：重申Edgewise Therapeutics(EWTX.US)评级，由优于大市调整至优于大市评级, 目标价由32.","url":"https://stock-news.laohu8.com/highlight/detail?id=2450975818","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450975818?lang=zh_cn&edition=full","pubTime":"2024-07-10 21:31","pubTimestamp":1720618265,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LENZ","BK4139","BK4007","BK4539","EWTX"],"gpt_icon":0},{"id":"2450021741","title":"小摩：维持Edgewise Therapeutics(EWTX.US)评级，由增持调整至增持评级, 目标价由27.00美元调整至30.","url":"https://stock-news.laohu8.com/highlight/detail?id=2450021741","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450021741?lang=zh_cn&edition=full","pubTime":"2024-07-09 23:04","pubTimestamp":1720537440,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0238689110.USD","LU1496350502.SGD","EWTX","LU0256863811.USD","BK4504","LU0417517546.SGD","LU2106854487.HKD","BK4581","LU0211327993.USD","LU1670628061.USD","LU0070302665.USD","LU1363072403.SGD","LU0496365809.HKD","LU1244550221.USD","LU1032466523.USD","IE00BJTD4N35.SGD","BK4007","LU1244550577.SGD","IE00BZ1G4Q59.USD","LU0208291251.USD","BK4539","LU0211326755.USD","IE00BWXC8680.SGD","LENZ","LU0211326839.USD","BK4566","LU0971096721.USD","LU0149725797.USD","LU1917777945.USD","IE00BJTD4V19.USD","LU2552382215.SGD","IE00BKVL7J92.USD","IE00B775SV38.USD","LU2552382058.USD","LU0882574139.USD","IE00BLSP4452.SGD","LU0211331839.USD","IE00BLSP4239.USD","LU0234572021.USD","IE0034235188.USD","LU1668664300.SGD","LU0310799852.SGD","LU1496350171.SGD","LU2023250504.SGD","BK4588","LU1162221912.USD","LU0211328371.USD","BK4207","BK4550","LU2552382132.HKD"],"gpt_icon":0},{"id":"2450015021","title":"Edgewise Therapeutics, Inc.盘中异动 早盘急速拉升5.02%报21.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450015021","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450015021?lang=zh_cn&edition=full","pubTime":"2024-07-09 22:51","pubTimestamp":1720536700,"startTime":"0","endTime":"0","summary":"北京时间2024年07月09日22时51分，Edgewise Therapeutics, Inc.股票出现波动，股价急速上涨5.02%。截至发稿，该股报21.97美元/股，成交量14.6011万股，换手率0.16%，振幅5.14%。Edgewise Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.52%。其相关个股中，Soligenix, Inc.、Uniqure N.V.、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Soligenix, Inc.、Longeveron Inc.、Anew Medical, Inc.较为活跃，换手率分别为7771.51%、231.54%、133.15%，振幅较大的相关个股有Soligenix, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 、Longeveron Inc.，振幅分别为317.50%、76.52%、50.19%。Edgewise Therapeutics, Inc.公司简介：Edgewise Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709225140941f574d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709225140941f574d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","BK4539","EWTX"],"gpt_icon":0},{"id":"2450060385","title":"美国研究综述-Alphabet、多米诺比萨、McKesson","url":"https://stock-news.laohu8.com/highlight/detail?id=2450060385","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450060385?lang=zh_cn&edition=full","pubTime":"2024-07-09 14:49","pubTimestamp":1720507794,"startTime":"0","endTime":"0","summary":"    路透7月9日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 Alphabet、Domino's Pizza 和 McKesson。要闻             * Alphabet Inc   ：杰富瑞将目标价从215美元上调至220美元             * Domino's Pizza Inc   ：贝尔德上调其评级至 \"跑赢大盘\"，目标价从530美元上调至580美元              * McKesson Corp   ：贝雅将目标价从679美元上调至694美元              * Teleflex Inc   ：Truist Securities将目标价从219美元上调至235美元             * Tradeweb Markets Inc   ：Raymond James将目标价从115美元上调至117美元  以下是路透周二报道的美国公司研究报告摘要。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0170899867.USD","BK4579","LU1430594728.SGD","LU0048573561.USD","BK4023","BK4576","DPZ","DVN","BK4585","IE00BJTD4V19.USD","COR","BK4503","LU2065169927.USD","LU2125154778.USD","SG9999004303.SGD","LU0742534661.SGD","LU0494093205.USD","CGC","GOOGL","LU0149725797.USD","LU0006061336.USD","LU0211328371.USD","DIN","LU1267930730.SGD","TEM","TFX","TW","LU0127658192.USD","EWTX","LU1983260115.SGD","CMG","EPR","KYMR","SIMO","IE00BKVL7J92.USD","LU0310800379.SGD","BK4112","BK4588","ACM","CRNX","LU0310800965.SGD","CAH","LU0320765059.SGD","DYN","SGXZ81514606.USD","ZETA","MCK","LU2087625088.SGD","LU0889566641.SGD","BK4141"],"gpt_icon":0},{"id":"2448169066","title":"Edgewise Therapeutics, Inc.盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448169066","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448169066?lang=zh_cn&edition=full","pubTime":"2024-07-03 00:10","pubTimestamp":1719936602,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日00时10分，Edgewise Therapeutics, Inc.股票出现异动，股价快速跳水5.00%。Edgewise Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.68%。其相关个股中，Zura Bio Limited C/Wts 、Ocean Biomedical Inc C/Wts 14/02/2028 、Annovis Bio, Inc.涨幅较大，Mustang Bio, Inc.、Gri Bio, Inc.、Geovax Labs, Inc.较为活跃，换手率分别为56.42%、49.80%、40.83%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Annovis Bio, Inc.、Anew Medical Inc C/Wts 21/06/2029 ，振幅分别为72.83%、43.24%、39.76%。Edgewise Therapeutics, Inc.公司简介：Edgewise Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703001003af90373d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703001003af90373d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","EWTX","BK4539","BK4139"],"gpt_icon":0},{"id":"2444116214","title":"Edgewise Therapeutics, Inc.盘中异动 大幅上涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444116214","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444116214?lang=zh_cn&edition=full","pubTime":"2024-06-20 21:31","pubTimestamp":1718890310,"startTime":"0","endTime":"0","summary":"北京时间2024年06月20日21时31分，Edgewise Therapeutics, Inc.股票出现波动，股价快速拉升5.07%。截至发稿，该股报17.00美元/股，成交量2896股，换手率0.00%，振幅0.00%。Edgewise Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。其相关个股中，Geovax Labs Inc C/Wts 29/09/2025、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Clearmind Medicine Inc.、Geovax Labs, Inc.、Trevena, Inc.较为活跃，换手率分别为325.57%、133.93%、120.10%，振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Cue Biopharma, Inc.、Celcuity Inc.，振幅分别为37199.25%、105.93%、102.42%。Edgewise Therapeutics, Inc.公司简介：Edgewise Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620213151941efd3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620213151941efd3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EWTX","LENZ","BK4539","BK4007"],"gpt_icon":0},{"id":"2436612841","title":"美国研究综述-阿里斯塔网络公司、新月能源公司、戴尔科技公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2436612841","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2436612841?lang=zh_cn&edition=full","pubTime":"2024-05-20 14:56","pubTimestamp":1716188173,"startTime":"0","endTime":"0","summary":"    路透5月20日 - 华尔街证券分析师周一调整了对几家美国上市公司的评级和目标价，其中包括 Arista Networks、Crescent Energy 和戴尔科技。* 戴尔科技公司  ：摩根大通将目标价从125美元上调至155美元              * Loar Holdings Inc   ：加拿大皇家银行给予 \"跑赢大盘 \"评级；目标价60美元              * Regeneron Pharmaceuticals Inc   ：Jefferies将其目标价从1,060美元上调至1,115美元。* 安特罗资源公司  ：Gerdes Energy Research将其评级从 \"买入 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LITE","AR","IE00BMPRXR70.SGD","LU2106854487.HKD","LU0109394709.USD","BK4170","BK4559","BK4182","CRGY","EWTX","ANET","LU1917777945.USD","BK4588","BK4007","BK4139","BK4515","BK4177","BK4551","BK4020","NMRA","KGS","BK4505","AZZ","BK4503","LU1974910355.USD","REGN","DELL","SNOW","LU0114720955.EUR","LU0289739699.SGD","BK4585","LU0109392836.USD","LU0289739343.SGD","BK4213","LU2023250504.SGD","FLO","LU0889565916.HKD","BK4212","BK4121","LU1803068979.SGD","HCAT","FTRE","LU0289961442.SGD","BHVN","IE00BMPRXN33.USD","DAR","BK4581","IIPR","PRMW","LOAR"],"gpt_icon":0},{"id":"2435304196","title":"Edgewise Therapeutics, Inc.盘中异动 股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435304196","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2435304196?lang=zh_cn&edition=full","pubTime":"2024-05-14 03:37","pubTimestamp":1715629031,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日03时37分，Edgewise Therapeutics, Inc.股票出现波动，股价大幅下挫5.02%。Edgewise Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.22%。其相关个股中，Dermata Therapeutics Inc C/Wts 、Revolution Medicines Inc C/Wts 17/12/2026 、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Allarity Therapeutics, Inc.、Transcode Therapeutics, Inc.、诺瓦瓦克斯医药较为活跃，换手率分别为126.67%、88.94%、83.22%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Revolution Medicines Inc C/Wts 17/12/2026 、Tevogen Bio Holdings Inc.，振幅分别为92.16%、85.56%、50.38%。Edgewise Therapeutics, Inc.公司简介：Edgewise Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405140337117927651d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405140337117927651d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EWTX","BK4539","BK4007","LENZ"],"gpt_icon":0},{"id":"2433210787","title":"Edgewise Therapeutics Inc    预计每股亏损 39 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433210787","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433210787?lang=zh_cn&edition=full","pubTime":"2024-05-08 00:33","pubTimestamp":1715099601,"startTime":"0","endTime":"0","summary":"   * Edgewise Therapeutics Inc    预计在5月9日公布截至2024年3月31日的业绩时，季度收入将不会有任何变化(预计)。*    * LSEG分析师对Edgewise Therapeutics Inc的平均预期是每股亏损39美分。* 华尔街对 Edgewise Therapeutics Inc 的 12 个月目标价中位数为 29.00 美元，高于其上次收盘价 20.34 美元。5月7日 - 本摘要于北京时间 5 月 7 日 16:33 机器生成。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","EWTX"],"gpt_icon":0},{"id":"2433852487","title":"Edgewise Therapeutics, Inc.盘中异动 急速拉升5.31%报21.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433852487","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433852487?lang=zh_cn&edition=full","pubTime":"2024-05-07 22:18","pubTimestamp":1715091518,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日22时18分，Edgewise Therapeutics, Inc.股票出现波动，股价大幅拉升5.31%。截至发稿，该股报21.42美元/股，成交量9.1724万股，换手率0.10%，振幅6.05%。Edgewise Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。其相关个股中，Lexaria Bioscience Corp C/Wts 14/01/2026 、Geovax Labs Inc C/Wts 29/09/2025、珐博进涨幅较大，Clearmind Medicine Inc.、Tc Biopharm  Plc、Allarity Therapeutics, Inc.较为活跃，换手率分别为1349.52%、161.12%、118.07%，振幅较大的相关个股有Tc Biopharm  Plc、Clearmind Medicine Inc.、Corvus Pharmaceuticals, Inc.，振幅分别为37.16%、34.19%、26.70%。Edgewise Therapeutics, Inc.公司简介：Edgewise Therapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050722183987e86224&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050722183987e86224&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","EWTX","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2425321697","title":"成分股Avidity Bio收跌11.07%，Edgewise Therapeutics跌10.70%，Summit Therapeutics Plc.","url":"https://stock-news.laohu8.com/highlight/detail?id=2425321697","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2425321697?lang=zh_cn&edition=full","pubTime":"2024-04-05 05:40","pubTimestamp":1712266807,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["BK4139","LENZ","BK4539","BK4585","BK1576","BK1141","BK1583","BK4007","EWTX","BMEA","03347"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.edgewisetx.com","stockEarnings":[{"period":"1week","weight":0.1216},{"period":"1month","weight":-0.1415},{"period":"3month","weight":0.0188},{"period":"6month","weight":0.0622},{"period":"1year","weight":1.6059},{"period":"ytd","weight":0.6865}],"compareEarnings":[{"period":"1week","weight":0.04},{"period":"1month","weight":-0.0047},{"period":"3month","weight":0.047},{"period":"6month","weight":0.1097},{"period":"1year","weight":0.2705},{"period":"ytd","weight":0.1662}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Edgewise Therapeutics, Inc.于2017年5月成立为特拉华州公司，总部位于科罗拉多州博尔德。 该公司是一家临床阶段的生物制药公司，致力于发现，开发和商业化针对严重，罕见的肌肉疾病的新疗法，这些药物对于医疗的需求尚未得到充分满足。公司的主要候选产品EDG-5506是一种口服小分子药物，旨在解决营养不良症的根本原因，包括杜氏肌营养不良（DMD）和贝克尔肌营养不良（BMD）。针对主要肌肉蛋白质和调节剂的精密药物候选产品的渠道，以解决广泛的遗传定义的肌肉疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.221382},{"month":2,"riseRate":0,"avgChangeRate":-0.093585},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.121355},{"month":4,"riseRate":0.25,"avgChangeRate":0.000577},{"month":5,"riseRate":0.5,"avgChangeRate":-0.024995},{"month":6,"riseRate":0.5,"avgChangeRate":-0.042597},{"month":7,"riseRate":0.25,"avgChangeRate":-0.019509},{"month":8,"riseRate":0.5,"avgChangeRate":-0.028064},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.019677},{"month":10,"riseRate":0.333333,"avgChangeRate":0.025789},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.017709},{"month":12,"riseRate":0.333333,"avgChangeRate":0.225126}],"exchange":"NASDAQ","name":"Edgewise Therapeutics, Inc.","nameEN":"Edgewise Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Edgewise Therapeutics, Inc.(EWTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Edgewise Therapeutics, Inc.(EWTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Edgewise Therapeutics, Inc.,EWTX,Edgewise Therapeutics, Inc.股票,Edgewise Therapeutics, Inc.股票老虎,Edgewise Therapeutics, Inc.股票老虎国际,Edgewise Therapeutics, Inc.行情,Edgewise Therapeutics, Inc.股票行情,Edgewise Therapeutics, Inc.股价,Edgewise Therapeutics, Inc.股市,Edgewise Therapeutics, Inc.股票价格,Edgewise Therapeutics, Inc.股票交易,Edgewise Therapeutics, Inc.股票购买,Edgewise Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Edgewise Therapeutics, Inc.(EWTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Edgewise Therapeutics, Inc.(EWTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}